KRAS G12C inhibitor 29
KRAS G12C inhibitor 29 is a KRAS G12C inhibitor extracted from patent WO2021252339A1, compound 3. KRAS G12C inhibitor 29 can be used for the research of cancer[1].
Product Specifications
CAS Number
[847337-63-7]
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-g12c-inhibitor-29.html
Solubility
10 mM in DMSO
Smiles
O=C(N1CC2=C(F)C=CC=C2Cl)N(C)C3=C(N4C(N(C5=CC=CC(C)=C5)CCC4)=N3)C1=O
Molecular Formula
C23H21ClFN5O2
Molecular Weight
453.90
References & Citations
[1]Fan J, et, al. Substituted purine-2,6-dione compounds as kras inhibitors. WO2021252339A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
![BOB1 (POU2AF1) Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI3B9]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
TA807923BM 100 µL
BOB1 (POU2AF1) Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI3B9]
Sign In for Pricing
View Details 
MBS6359841-01 0.2 mL
TTC13, NT (TTC13, Tetratricopeptide repeat protein 13) (Azide free) (HRP)
Sign In for Pricing
View Details MBS6359841-02 5x 0.2 mL
TTC13, NT (TTC13, Tetratricopeptide repeat protein 13) (Azide free) (HRP)
Sign In for Pricing
View Details 
MBS7009542-01 0.02 mg
Recombinant Bifidobacterium longum ATP synthase subunit b (atpF)
Sign In for Pricing
View Details